MO

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 1999, for Philip Morris Companies Inc. (Note: The request metadata listed "Altria Group," but the filing text identifies the registrant as Philip Morris Companies Inc., the predecessor to Altria). The company operates in domestic and international tobacco, food (North American and International), beer, and financial services segments. The financial statements are unaudited.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 6.1% to $19.5 billion, driven primarily by a 33.7% increase in domestic tobacco revenues due to price increases ($1.4 billion), partially offset by lower volume.
• Profitability: Operating income rose 23.3% to $3.2 billion. This increase is largely attributable to the absence of the $806 million litigation settlement charge recorded in Q1 1998. Excluding separation program charges in both periods, underlying operating income decreased slightly (0.4%).
• Cash Flow: Net cash provided by operating activities surged to $1.95 billion from $471 million, primarily due to the timing of collecting settlement-related revenues prior to remittance to state governments.
• Debt Reduction: Total consumer products debt decreased to $13.1 billion from $14.0 billion, aided by net debt repayments of $730 million in the quarter.
• Shareholder Returns: The company repurchased 15.6 million shares for $649 million and paid dividends of $1.1 billion.

Guidance, Outlook, Risks, and Unusual Items

• Unusual Items: Q1 1999 operating income included pre-tax charges of $130 million for separation programs at the Louisville, Kentucky plant and $157 million for workforce reductions in the North American food segment. Q1 1998 included an $806 million charge for tobacco litigation settlements.
• Legal Contingencies: The company faces substantial litigation risks, including approximately 485 individual smoking and health cases and 60 class actions in the U.S. as of May 1, 1999. The Master Settlement Agreement (MSA) requires the industry to make substantial annual payments starting at $4.2 billion in 1999, rising to $9.2 billion in 2000.
• Regulatory Risks: The FDA's attempt to regulate cigarettes as "drugs" was ruled invalid by the Fourth Circuit Court of Appeals, but the U.S. Supreme Court agreed to review the decision in April 1999. Excise tax increases are scheduled for 2000 and 2002.
• Year 2000 (Y2K): The company estimates total Y2K compliance costs at approximately $550 million, with 90% of remediation complete as of March 31, 1999. Risks include potential disruptions from third-party vendors and utilities.
• Currency and Economy: A strengthening U.S. dollar against the euro and economic instability in Eastern Europe, Asia, and Latin America are expected to adversely affect future results.

Investor Verification Checklist

• MSA Payment Obligations: Verify the impact of the Master Settlement Agreement's escalating annual payments (starting at $4.2 billion in 1999) on future cash flows and pricing strategies.
• Volume Trends: Monitor domestic tobacco shipment volumes, which declined 9.6% in Q1 1999, to assess the long-term impact of price increases and settlement-related inventory destocking.
• Supreme Court Ruling: Track the outcome of the Supreme Court review regarding the FDA's authority to regulate tobacco products.
• Y2K Readiness: Confirm the status of third-party vendor and utility readiness for the Year 2000 transition to mitigate supply chain disruption risks.
• Separation Charges: Verify the timing and total cost of the remaining $70 million in separation charges expected in Q2 1999 related to the Louisville plant closure.